Chemical Proteomics: Drug Targets, Drug Selectivity, MoA and Resistance



April 23, 2013

This presentation gives examples for how mass spectrometry based chemical proteomics can aid at various stages in the drug discovery process including the identification of new drug targets, the selectivity of kinase inhibitors, the elucidation of the mechanism of action of drugs targeting HSP90 and identify mechanisms of resistance against targeted kinase inhibitors.

Drug DiscoveryMass SpectrometryMicrofluidicsProteomics and Metabolomics

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.